Characteristics and survival of 4N and non-4N metastatic neuroblastoma across treatment eras: A report from the International Neuroblastoma Risk Group Task Force. Harnessing OMOP-CDM for multisite ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results